Fernando Albericio, PhD
Research Professor, School of Chemistry
University of Kwazulu-Natal
Julia Alterman, Ph.D.
Assistant Professor, RNA Therapeutics Institute
University of Massachusetts Chan Medical
Dr. Daniel Bachmann, PhD
Business Development Manager
Bachem AG
Victor Beaumont, PhD
Strategic Market Development Specialist
Bruker UK Limited
Christian Becker, Ph.D.
Professor and Head of the Institute of Biological
University of Vienna
Ralph Beneke
Product Specialist, Genomics
Agilent Technologies
Riccardo Bernasconi, Ph.D.
Director Business Development
Bachem
Lucas Bethge, Ph.D.
Vice President and Group Leader Oligonucleot
Silence Therapeutics
Dr. Nikita Brodyagin, PhD
Senior Scientist
Tessera Therapeutics
Tracey Burr, Ph.D.
Executive Director, CMC Regulatory Affairs
Ionis Pharmaceuticals
Dr. Walter Cabri, PhD
Full Professor of Organic Chemistry
University of Bologna
Judy Carmody, Ph.D.
Founder and Principal Consultant
Carmody Quality Solutions, LLC
Simone Carneiro, Ph.D.
Postdoctoral Fellow
LMU Munich
Melanie Cerullo
Cheif Quality & Regulatory Officer
ReciBioPharm
Osama Chahrour, PhD
Principal Scientist, Chemical Development
AstraZeneca
Jing Chen, Ph.D.
Director of Discovery DMPK
Arrowhead Pharmaceuticals
Kangming Chen, PhD
Head of mRNA & Plasmid Department
GenScript
Chris Chorley
Associate Director, Global Regulatory CMC, ASO Early Development Lead
Biogen
Sophie Corbet
EMEA Bioprocessing Technical Service Manager
DuPont
David Craik, PhD
Professor of Biomolecular Structure
University of Queensland
Hagen Cramer, PhD
Chief Technology Officer
QurAlis
Stanley Crooke, MD, PhD
Founder and CEO
n-lorem Foundation
Beatriz De La Torre, Ph.D.
Research Professor, Laboratory of Medicine and Med
University Of KwaZulu-Natal
Anthony Ehkirch, Ph.D.
Principal Scientist and Analytical Expert
Novartis
Tomaz Einfalt, PhD
Principal Investigator II xRNA
Novartis Institutes for BioMedical Research
Patrick Endres
Product Management EMEA
Tosoh Bioscience GmbH
William Fang
Vice President of Oligonucleotide and Peptide Development
WuXi TIDES
Marah Faron
Digital Innovation Lead
GSK
Yannick Fillon, PhD
Head of Oligonucleotide Process Chemistry
Daniela Fischer, Ph.D.
Associate Director Regulatory Affairs CMC
Novartis Pharmaceutical Manufacturing
Mr. Jonathan Fox
Consulting Scientist
Waters Corporation
Ashish Garg, Ph.D.
Director, Drug Product Development
Eli Lilly and Company
Derek Gauntlett
Director, Process Chemistry, Nucleic Acid Development & Manufacturing
Codexis
Xavier Gerard, Ph.D.
Field Application Scientist, EMEA
Thermo Fisher Scientific
Youme Gim
Team Leader, Oligonucleotide CDMO I
ST Pharm
Amanda Haas
Business Development Manager, Gene Editing Therapeutics
Alastair Hay, Ph.D.
Vice President, Peptides
Almac
Christian Heinis, PhD
Associate Professor
Ecole PolyTechnique Federale de Lausanne
Claudia Höbartner, Ph.D.
Professor of Organic Chemistry
University of Würzburg
Vusala Ibrahimova, Ph.D.
Research Scientist
CureVac SE
Frank Jaschinski, PhD.
Chief Scientific Officer
Secarna Pharmaceuticals
Jörg Kittelmann, Ph.D.
Principal Scientist, CMC Downstream API Development
Novo Nordisk
Alexander Kleinsmann, PhD
Director R&D, CMC Development
Laurent Knerr, Ph.D.
Principal Scientist
Troels Koch, PhD
MiNa Therapeutics
Dr. Anna Koijen, PhD
EnzyTag B.V.
Erich Koller, Ph.D.
Senior Principal Scientist
Roche Innovation Center Basel
Tom Krebstakies, PhD
Sales Manager - Europe & Asia
Asahi Kasei Bioprocess
Christoph Kroener, Ph.D.
Senior Director CMC IVAC Portfolio
BioNTech AG
Jesper Lau, PhD
Vice President, Digital Science & Innovation
Novo Nordisk A/S
Ekkehard Leberer, PhD
Professor of Biochemistry and CEO
ELBIOCON
Charlotte LeKieffre, PhD
Biopharma Application Specialist
Jiazhen Liang, PhD
Lennart Lindfors, Ph.D.
Senior Principal Scientist, Pharmaceutical Science
Beatriz Llamusi, PhD
Chief Executive Officer & Co Founder
Arthex Biotech S.L.
Stephen Lock, PhD
Senior Market Development Manager
SCIEX
Olivier Ludemann-Hombourger, PhD
Director, Global Innovation and Technology
PolyPeptide Group
Morten Lundh, Ph.D.
Director, Drug Discovery Innovation
Gubra A/S
Leila Malik, PhD
CMC Project Director
Joan Malmstrøm, Ph.D.
Principal Scientist, CMC Analytical Support
Aram Mangasarian, Ph.D.
Chief Executive Officer
TME Pharma
Jody Mason, PhD
Professor of Biochemistry
University of Bath
Patrizio Mattei, PhD
Expert Scientist, Medicinal Chemistry
F. Hoffmann-La Roche Ltd.
Sonja Merkas, Ph.D.
Founder
Livinovea
Dr. Mathew Miller, PhD
Director, Life Science and RNA Technologies
Dr. Alejandro Montaner
CEO
Immunalgia Therapeutics
Bruce Morimoto, PhD
Vice President, Drug Development
Alto Neuroscience
Jale Muslehiddinoglu, PhD
Vice President of Strategic Innovation
Dr. Ganesh Nawale, PhD
Senior Scientist, Oligonucleotides
Cytiva
Peter Nielsen, PhD
Professor
University of Copenhagen
Sheena Ong, PhD
Scientist
Biosynth
Chris Oswald
Founder, Owner, and Principal Consultant
Coswald Consulting LLC
Trine Puggaard Petersen, PhD
Specialist, CMC API Chemical Development
Tamara Pfaff
Head of Preclinical Development
AiCuris Anti-infective Cures AG
Barbara Pfaff, PhD
QC Manager Molecular Sequencing
BioSpring GmbH
Thi Lan Phuong Pham
Project Lead GMP and Large Scale Production
Daniel Pinchuk, PhD
Oligonucleotide Team Leader, Chemical R&D
Teva
Gerard Platenburg, PhD
ProQR Therapeutics
Dr. Elias Post, PhD
Synaffix/Lonza
Leo Qian, PhD
Co-Founder and Vice President, Discovery Research
Entrada Therapeutics
Dr. Jyothi Rangineni, PhD
Senior Process Scientist
Fluid Air
Marcus Reay
DelSiTech Ltd.
Thomas Rupp
Managing Director
Axolabs Berlin GmbH
Eike-Fabian Sachs, PhD
Head of Development Frankfurt
CordenPharma International GmbH
Yogesh Sanghvi, PhD
President
Rasayan Inc.
Gajan Santhakumar, Ph.D.
Associate Principal Scientist, Early Chemical Development
Dr. Christina Schroeder, Ph.D.
Senior Fellow, Peptide Therapeutics
Genentech
Dr. Ronak Shah, PhD
Director
Beam Therapeutics
Filippo Sladojevich, Ph.D.
Hoffmann-La Roche
Steven Stanton
Senior Scientist in Oligonucleotide Process Chemistry
Bryan Stroup
Senior Validation Scientist, Process Development
Nitto Denko Avecia
Daisuke Takahashi, PhD
Executive Specialist
Ajinomoto Co. Inc.
George Thom
Director, mRNA Team Leader
Karina Thorn, PhD
Corporate VP and Head of Research, Global Nucleic Acid Therapies (GNAT)
Jyothi Thundimadathil, Ph.D.
Director of Drug Substance Development CMC
Carmot Therapeutics
René Thürmer, PhD
Deputy Head
BfArM Federal Institute for Drugs & Medical Devices
Michael Tikhonov
Analytical Group Manager, Oligonucleotides and Peptides
Sergey Tsukanov, Ph.D.
Senior Director Chemistry
Eric van der Veer, PhD
Chief Innovation Officer
Hybridize Therapeutics
Dr. Janika Viereck, PhD
Head of R&D
Cardior Pharmaceuticals GmbH - a Novo Nordisk company
Letizia Volpe, Ph.D.
Site MS&T Head Chemical Operations
Antti Vuolanto
Herantis Pharma plc
Zi Jun Emma Wang, PhD
YolTech Therapeutics
Daniel Waschke, Ph.D.
Technical Regulatory Manager
Mike Webb, Ph.D.
Mike Webb Pharma
Dr. Tsuyoshi Yamamoto, PhD
CSO
Liid Pharmaceuticals
Yi Yang, PhD
Lead Scientist
Ferring Pharmaceuticals A/S
